Regulatory & Legal

A Texas utility automated 90% of its collection calls with AI. The real story isn't just efficiency, but how it creates a fairer, more humane process.

Chatham Lodging Trust's dividend hike isn't just a payout. It’s a strategic signal about the future of upscale travel and savvy hotel investment.

The 2025 proxy season saw record director support as investors prioritized financials, yet dissent over executive pay signals a new battleground.

With a key Australian security certification, Ivalua isn't just checking a box—it's executing a strategic disruption in government procurement.

With a new patent, this biotech targets the massive orthopedics market. But can its novel fibroblast therapy overcome steep financial and clinical hurdles?

A new partnership aims to unify cybersecurity and operations in smart buildings, but can it solve the deep-rooted trust and vulnerability issues?

USA Rare Earth is accelerating its timeline to mine critical minerals by two years. Can innovative tech and bold strategy break foreign supply chain dominance?

With a key FAA filing, Electra's hybrid-electric EL9 moves closer to reality, promising to bypass airports with 150-foot takeoffs and landings.

The space firm secures vital cash through a complex warrant deal, but at what cost to shareholders? All eyes are now on a critical investor vote.

A new partnership aims to commercialize Arbli™, the first liquid losartan, leveraging a digital platform to solve patient adherence and capture market share.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

India's new Labour Code 2025 is forcing a strategic pivot. Discover how firms are turning regulatory mandates into a competitive edge for productivity.

As drone attacks paralyze European airports, an Israeli tech firm's 'soft kill' net system emerges as a key contender for NATO's defense strategy.

MediWound's burn treatment now prevents traumatic tattoos from blasts and accidents, signaling a major strategic expansion and a new era in trauma care.

As AI fuels a new arms race in cyberspace, an innovative training model emerges to arm human defenders. Is this the future of cybersecurity education?

CEO Amy Perry’s influence is celebrated, but her true test is securing Banner’s vast, AI-driven ecosystem from the escalating threats of the digital age.

Beyond a simple FDA approval, Amneal's entry into the epinephrine vial market is a calculated move to fix a broken supply chain and drive growth.

Apollo Commercial Real Estate Finance offers a tempting 10% yield, but can it last? We dive into the risks and rewards of this high-stakes CRE play.

Grant Eason's promotion to Managing Director reveals more than a career move; it's a key to Capital Southwest's strategy in the heated private credit market.

CEO Adrian Mendes' major buy-in signals deep confidence as Perimeter Medical AI navigates FDA approval for its game-changing cancer surgery technology.